An immune epigenetic insight to COVID-19 infection

Epigenomics. 2021 Mar;13(6):465-480. doi: 10.2217/epi-2020-0349. Epub 2021 Mar 9.

Abstract

Severe acute respiratory syndrome coronavirus-2 is a positive-sense RNA virus, a causal agent of ongoing COVID-19 pandemic. ACE2R methylation across three CpG sites (cg04013915, cg08559914, cg03536816) determines the host cell's entry. It regulates ACE2 expression by controlling the SIRT1 and KDM5B activity. Further, it regulates Type I and III IFN response by modulating H3K27me3 and H3K4me3 histone mark. SARS-CoV-2 protein with bromodomain and protein E mimics bromodomain histones and evades from host immune response. The 2'-O MTases mimics the host's cap1 structure and plays a vital role in immune evasion through Hsp90-mediated epigenetic process to hijack the infected cells. Although the current review highlighted the critical epigenetic events associated with SARS-CoV-2 immune evasion, the detailed mechanism is yet to be elucidated.

Keywords: ACE2; COVID-19; DNA methylation; SARS-CoV-2; histone PTMs; host-virus interaction; immune evasion; immunoepigenetics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiotensin-Converting Enzyme 2 / genetics
  • Antigen Presentation
  • COVID-19 / genetics*
  • COVID-19 / immunology*
  • DNA Methylation
  • Epigenesis, Genetic*
  • HSP90 Heat-Shock Proteins / genetics
  • Histones
  • Humans
  • Immune Evasion*
  • SARS-CoV-2 / physiology
  • Virus Internalization

Substances

  • HSP90 Heat-Shock Proteins
  • Histones
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2